Analyst Reco. HilleVax, Inc.

Equities

HLVX

US43157M1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
15.84 ^USD	+1.73%		+14.45%	-1.31%

May. 09	HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 05	Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing	Apr. 05	MT
Stifel Adjusts HilleVax Price Target to $34 From $30, Maintains Buy Rating	Mar. 21	MT
HilleVax Insider Sold Shares Worth $985,536,428, According to a Recent SEC Filing	Mar. 21	MT
HilleVax Proposes $500 Million Offering of Equity, Debt Securities in Shelf Registration	Mar. 20	MT
HC Wainwright Initiates HilleVax With Buy Rating	Dec. 13	MT
JPMorgan Adjusts Price Target on HilleVax to $22 From $23, Maintains Overweight Rating	23-05-16	MT
Factbox-U.S. IPO activity plunges as Ukraine war triggers volatility	22-08-10	RE
SVB Securities Initiates HilleVax at Outperform With $30 Price Target	22-05-24	MT
Guggenheim Starts HilleVax at Buy With $40 Price Target	22-05-24	MT
JPMorgan Starts HilleVax at Overweight With $24 Price Target	22-05-24	MT
Stifel Starts HilleVax at Buy With $34 Price Target	22-05-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW